4//SEC Filing
Dulac Edward J III 4
Accession 0001209191-23-059103
CIK 0001434316other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:01 PM ET
Size
4.8 KB
Accession
0001209191-23-059103
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-12-18$3.50/sh−1,585$5,548→ 117,985 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:01 PM ET
- Size
- 4.8 KB